Literature DB >> 8895922

Prospective study of human immunodeficiency virus 1-related disease among 512 infants born to infected women in New York City. The New York City Perinatal HIV Transmission Collaborative Study Group.

M Bamji1, D M Thea, J Weedon, K Krasinski, P B Matheson, P Thomas, G Lambert, E J Abrams, R Steketee, M Heagarty.   

Abstract

OBJECTIVE: To determine the incidence of HIV-1-related clinical findings, mortality and predictors of death in a cohort of HIV-exposed infants followed from birth.
METHODS: Data were collected approximately bimonthly during the first and second year of life and used in Kaplan-Meier and Cox proportional hazards survival analyses to predict time to the development of symptoms and death.
RESULTS: One hundred sixteen infected and 396 uninfected infants were followed for a median of 26 months at 7 New York City hospitals from 1986 to 1995. Two or more nonspecific HIV-related symptoms, AIDS or death occurred in 83% of infected children by the first year. Fifty infected infants (43%) developed AIDS and 19 (38%) of these had Pneumocystis carinii pneumonia. Estimated median age at AIDS/death was 30 months and 64% of infected children remained alive and AIDS-free at 1 year. Estimated infant mortality among infected children was 160/1000 live births, and median survival after AIDS was 21 months; 55% of infected children survived > 12 months after diagnosis of AIDS. P. carinii pneumonia was the most common cause of death. Although birth CD4 values did not predict AIDS or death, CD4 counts as early as 6 months of age were highly correlated with both. Thirteen (68%) of 19 infants who remained AIDS-free up to 3 to 6 months of age with CD4 count < or = 1500 cells/microliters subsequently developed AIDS vs. 18 (30%) of 61 with CD4 count > 1500 (P = 0.0001).
CONCLUSIONS: Most HIV-1-infected infants develop disease in the first year of life. AIDS or death can be predicted by a threshold CD4 count of 1500 cells/microliters at 3 to 6 months of age.

Entities:  

Mesh:

Year:  1996        PMID: 8895922     DOI: 10.1097/00006454-199610000-00012

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  6 in total

1.  Functional analysis of HIV type 1 Nef gene variants from adolescent and adult survivors of perinatal infection.

Authors:  Jun Zuo; Jeffrey Suen; Alanna Wong; Martha Lewis; Ali Ayub; Marvin Belzer; Joseph Church; Otto O Yang; Paul Krogstad
Journal:  AIDS Res Hum Retroviruses       Date:  2011-10-03       Impact factor: 2.205

2.  Enteric virus infections and diarrhea in healthy and human immunodeficiency virus-infected children.

Authors:  M B Liste; I Natera; J A Suarez; F H Pujol; F Liprandi; J E Ludert
Journal:  J Clin Microbiol       Date:  2000-08       Impact factor: 5.948

3.  Burkitt's lymphoma mimicking EBV disease as first sign of vertical HIV infection in an adolescent.

Authors:  Veronica Santilli; Nadia Mora; Angela Aquilani; Hyppolite K Tchidjou; Giuseppe Pontrelli; Rita De Vito; Alessandra Lombardi; Stefania Bernardi; Paolo Palma
Journal:  Ital J Pediatr       Date:  2010-04-23       Impact factor: 2.638

Review 4.  Patterns of postnatal growth in HIV-infected and HIV-exposed children.

Authors:  Sheila Isanaka; Christopher Duggan; Wafaie W Fawzi
Journal:  Nutr Rev       Date:  2009-06       Impact factor: 7.110

5.  Predictors of early mortality in a cohort of human immunodeficiency virus type 1-infected african children.

Authors:  Elizabeth M Obimbo; Dorothy A Mbori-Ngacha; James O Ochieng; Barbra A Richardson; Phelgona A Otieno; Rose Bosire; Carey Farquhar; Julie Overbaugh; Grace C John-Stewart
Journal:  Pediatr Infect Dis J       Date:  2004-06       Impact factor: 2.129

Review 6.  Immunology of pediatric HIV infection.

Authors:  Nicole H Tobin; Grace M Aldrovandi
Journal:  Immunol Rev       Date:  2013-07       Impact factor: 12.988

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.